AbbVie Inc. (ABBV) has risen to the #77 spot in the S&P 500 rankings, overtaking Ball Corp (BALL), according to an analysis by ETF Channel. This shift highlights AbbVie’s improved position among major brokerages analyzing stocks in the index.
As of midday Tuesday, AbbVie is trading down approximately 0.4%, while Ball Corp has seen a decline of about 1.5%. This performance comparison follows a three-month price history analysis of both companies within the S&P 500.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
